Tens of thousands of real-world geographic atrophy patients were analyzed in a retrospective database study. How did GA progress—and how do these data inform our understanding of GA? Ted Leng, MD, stopped by the show to share the findings from his research on the natural history of GA, which he recently delivered on the podium in Lisbon. And Michae…

Jacob Lang, OD, FAAO, shares his knowledge of innovative therapies for dry eye with Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO. He discusses drugs in development that target pathways involved in ocular surface disease, such as reactive aldehyde species inhibitors, transient receptor potential receptors, and more.…

In this special episode of The MOD Pod, Cecelia Koetting, OD, FAAO, Dipl ABO, interviews a diverse group of attendees from MOD Live 2024. She speaks with program chairs, faculty, newcomers, and returning attendees, capturing a wide range of perspectives from the event.بقلم Modern Optometry

Sebastian Heersink, MD, joins to contribute to this season’s theme of surgical horror stories. He talks with Blake Williamson, MD, MPH, and Gary Wörtz, MD, about his experience performing cataract surgery on his father and former guest of the podcast, Marnix Heersink, MD. Dr. Sebastian Heersink recounts how he managed the stress of operating on a f…

What is the relationship between retinal artery occlusion (RAO) and death, stroke, or myocardial infarction? Moderator Katherine Talcott, MD, is joined by Kyle Kovacs, MD, and Phoebe Mellen, MD, to explore the latest contribution to the literature on this topic. After the break, they discuss how best to manage patients who present to the clinic wit…

Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, discuss the benefits of using radio frequency to treat conjunctivochalasis (CCH) with Edward H. Jaccoma, MD, an ophthalmologist who specializes in dry eye and ocular aesthetics. Dr. Jaccoma also offers his insights for patient education, managing cases of CCH that don’t go entirely as…

Could inhibition of C1q effectively halt the progression of GA? Joel Pearlman, MD, PhD, sat down to discuss findings from the phase 2 ARCHER study, which evaluated ANX007 (Annexon) in patients with GA. He tells us what happened when patients were dosed with ANX007 for 1 year—and what occurred when patients stopped receiving treatment. And later, Di…

Cecelia Koetting, OD, FAAO, Dipl ABO, invites guest Julie Poteet, OD, MS, CNS, FOWNS, to the episode to talk about nutrition's role in the medical field and how it affects patients' ocular and systemic health. Dr. Koetting also speaks with Thomas Kislan, OD, on the topic of inflammatory dry eye. They cover diagnosis tactics, management options, and…

Does switching long-term wet AMD patients to faricimab (Vabysmo, Genentech/Roche) result in meaningful change to disease presentation? Join New Retina Radio Journal Club host Ben Young, MD, MS, and panelists Lediana Goduni, MD, and Josh Uhr, MD, as they break down a recent real-world study published in the literature. After the break, they review w…

The Port Delivery System with Ranibizumab (PDS; Susvimo, Genentech) was shown to be effective for wet AMD treatment. What did the PAVILION study find when it came to treating diabetic retinopathy out to 100 weeks? Margaret Chang, MD, summarized the PAVILION study’s 2-year safety and efficacy findings regarding the PDS in patients with DR but no DME…

Arsham Sheybani, MD, joins the podcast to continue this season’s theme of surgical horror stories. He shares a case example with Blake Williamson, MD, MPH, and Gary Wörtz, MD, in which he performed lensectomy in the eye of a 60-year-old woman who presented with angle-closure glaucoma and very high IOP. Following routine phacoemulsification, the ant…

Nandini Venkateswaran, MD, joins Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, this month on To the Point to share her insights on preoperative ocular surface considerations. Dr. Venkateswaran offers her approach to optimizing the ocular surface, educating patients on the importance of properly managing dry eye, and varying her d…

Is avacincaptad pegol (Izervay, Astellas) effective in patients with major ellipsoid zone attenuation at baseline? Katherine Talcott, MD, stopped by our studio in Stockholm during ASRS with a top-line summary of her lecture at this year’s meeting. And Sunir Garg, MD, joined us for a conversation about the GALE study, which assessed 36 months of con…

On The MOD Pod this month, Cecelia Koetting, OD, FAAO, Dipl ABO, hosts Erich A. Hinel, OD, MS, FAAO, and Luke B. Lindsell, OD, MD, to talk about their upcoming article in Modern Optometry on considerations for patients with cataracts and retinal disease. Specifically, the two give tips on what to keep top of mind when comanaging these patients. Dr.…

Continuing this season’s theme of surgical horror stories, Neda Shamie, MD, joins Gary Wörtz, MD, to share an experience from early in her career when she faced an unexpected complication. While performing penetrating keratoplasty on a well-known patient, Dr. Shamie encountered an expulsive hemorrhage. She highlights the value of mentorship in thes…

Patients with DME in DRCR Retina Network Protocol AC were switched from bevacizumab to aflibercept if they met specific switch criteria. Where there any baseline factors that predicted a switch? Moderator Rebecca Soares, MD, sits down with panelists Matt Starr, MD, and Nikisha Kothari, MD, to review this study, ask whether the findings are clinical…

One of the challenges associated with current anti-VEGF therapies for the management of DME is the need for frequent injections and the potential impact on adherence and vision outcomes. Join Dr. John Kitchens and Dr. Maria Berrocal as they share their experiences treating their DME patients using a therapy with a novel mechanism of action, and how…

Julie Poteet, OD, MS, CNS, FONS, joins Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, on this month’s episode of To the Point. An expert on nutrition and ocular health, Dr. Poteet discusses what the research has shown regarding the benefits of dietary supplementation for managing ocular surface disease, new products on the market,…

This month on the The MOD Pod, host Cecelia Koetting, OD, FAAO, Dipl ABO, connects with Kaeleen Franson, OD, about the prevalence of myopia and some of the top takeaways from Dr. Franson's article on managing the condition, which appears in the July/August issue of Modern Optometry. Dr. Koetting then speaks with Marc Bloomenstein, OD, FAAO, who exp…

What did a review of the AAO IRIS Registry reveal about the rates of retinal vein occlusion (RVO) during the COVID-19 pandemic? Moderator Katherine Talcott, MD, sits down with Phoebe Mellen, MD, and Kyle Kovacs, MD, to review the study's conclusion that RVO rates did not increase during the pandemic, discuss challenges about talking to patients see…

Recent studies have proven the therapeutic viability of a different approach in treating retinal vascular diseases. Join Dr. John Kitchens, Dr. Margaret Chang, and Dr. David Chin Yee as they discuss their clinical experiences using a therapy with a novel mechanism of action in patients with nAMD and DME. And, learn how they approach managing patien…

In the second episode of this 2-part series, moderator Paul Hahn, MD, PhD, and panelists Durga Borkar, MD, MMCi, and Ted Leng, MD, turn to the findings of FARETINA-AMD and FARETINA-DME, which rely on real-world outcomes as documented in the AAO IRIS Registry. What can retina specialists learn from these studies, and how might these studies' finding…

William Trattler, MD, joins Blake Williamson, MD, MPH, and Gary Wörtz, MD, to share a story in which a referring optometrist’s family member presented with dark brunescent cataracts in both eyes. He describes his initial approach and technique for managing these advanced cataracts, including the unexpected complication of a dropped lens and capsula…

Jennifer Shaba, OD, joins Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, on the latest episode to share her story about opening her own dry eye practice focused on regenerative medicine and holistic eye care. Dr. Shaba offers advice for optometrists at the very beginning of their own journey in dry eye.…

Protocol AA might be complete—but analysis of its data is far from over. What did that study’s data tell us about the relationship between leakage and DR severity? Justis Ehlers, MD, breaks down what he and his team uncovered when examining ultra-widefield images from Protocol AA, and helps us understand how machine learning might be used in future…

Cecelia Koetting, OD, FAAO, Dipl ABO, is joined by guest Steven Sorkin, OD, FSLS, on this episode of The MOD Pod, where they talk about the article on topical and systemic drugs that can affect the cornea that Dr. Sorkin recently wrote for Modern Optometry with his co-author, Nicolle Wah, OD. In the second half of the episode, Dr. Koetting gets int…

How do outcomes differ for RRD patients at risk of PVR following PPV alone or combined PPV/scleral buckling? Moderator David Xu, MD, hears from panelists Barton Blackorby, MD, and Prethy Rao, MD, MPH, about a recent peer-reviewed paper published in Ophthalmology Retina covering surgical outcomes of patients with RRD who were considered high risk fo…

Paul Walton, MD, continues the discussion with Blake Williamson, MD, MPH, and Gary Wörtz, MD, on approaches to anesthesia and nuances to manage potentially difficult patients during cataract and refractive surgery. Dr. Walton shares pearls to ensure a smooth day in the operating room, mitigating potential ophthalmology ‘horror stories.’…

Could next-generation anti-VEGF agents such as faricimab (Vabysmo, Genentech/Roche) and high-dose aflibercept (Eylea HD, Regeneron) be dosed as infrequently as every 20 weeks without sacrificing efficacy? And even if there are data that suggest that finding, would anyone actually adopt an interval that long in wet AMD patients? Philip Storey, MD, f…

David RP Almeida, MD, PhD, MBA; Lisa Faia, MD; and Chris Riemann, MD, return for the second episode in this podcast miniseries, in which they review a trio of real-world GA cases, explore what early responses to treatment look like, and ask how to address GA in the presence of wet AMD.بقلم Retina Today

Join David RP Almeida, MD, PhD, MBA; Lisa Faia, MD; and Chris Riemann, MD, as they assess which clinical and non-clinical characteristics drive their decision-making in patients with geographic atrophy (GA). After the break, Dr. Faia shares a real-world case from her clinic in which a patient who was lost to follow-up returns to consider treatment.…

What conclusions can be drawn from a cross-trial comparison of randomized clinical trials assessing the safety and efficacy of anti-VEGF agents used in the treatment of AMD and DME? Paul Hahn, MD, PhD, sits down with Durga Borkar, MD, MMCi, and Ted Leng, MD, to review a recent presentation by Dr. Leng on this topic, and to examine the clinical rele…

Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, are joined by retina specialist Srinivas Kondapalli, MD, who developed the Rinsada Irrigating Lid Retractor, which effectively cleanses the conjunctival fornix, palpebral conjunctiva, and bulbar conjunctiva.بقلم Modern Optometry

Check out the latest episode of The MOD Pod, where Cecelia Koetting, OD, FAAO, Dipl ABO, has an engaging conversation with Jason E. Compton, OD, FAAO, and Mahnia Madan, OD, FAAO, about their article on eyelash enhancements, which appears in the May/June issue Modern Optometry. In the second half of the episode, Dr. Koetting has a candid chat with J…

Biosimilars in retina are here. How are practices integrating them into their clinics? And how do they navigate issues around payer policy, protocol changes, and ensuring continuity of care? Moderator John Kitchens, MD, sits down with retina specialist Dave Brown, MD, and Kristin Yockus, the VP of Process Integrations at Retina Consultants of Ameri…

Paul Walton, MD, joins Blake Williamson, MD, MPH, and Gary Wörtz, MD, to share concepts to help cataract and refractive surgeons avoid horror stories in the OR. He says the goal should always be to have a “boring” day, emphasizing the importance of communication and understanding with patients. The surgeons also detail their approaches to anesthesi…

How do endophthalmitis rates after intravitreal injection differ after using povidone-iodine compared with chlorhexidine? Moderator Sruthi Arepalli, MD, hears from panelists Vaidehi Dedania, MD, and Rebecca Soares, MD, MPH, about a recent peer-reviewed retrospective cohort study on this topic. After the break, the trio discuss how to manage patient…

Performing surgery for symptomatic vitreous opacities (SVO) was once verboten in retina medicine, but the field has seen a sea-change in mindset over the past decade. In this podcast, optometric thought leader Alison Bozung, OD, is joined by an esteemed panel of retina surgeons to discuss why more retina surgeons are willing to perform vitrectomy f…

This month on The MOD Pod, Cecelia Koetting, OD, FAAO, Dipl ABO, invites Damaris Raymondi, OD, FAAO, and Jason Besecker, OD, MS, to discuss their recent articles in Modern Optometry. Have a listen as Dr. Raymondi shares extra details about the patient experience that opened her eyes to the transformative effect that offering at-home visits can have…

Performing surgery for symptomatic vitreous opacities (SVO) was once verboten in retina medicine, but the field has seen a sea-change in mindset over the past decade. In this podcast, moderator John Kitchens, MD, is joined by Edwin H. Ryan, MD; Christina Y. Weng, MD, MBA; and Alison Bozung, OD, to explore why surgery for SVO has become more palatab…

Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, catch up with Crystal M. Brimer, OD, FAAO, to talk about her prolific journey in dry eye. Dr. Brimer discusses opening her own practice, creating the Dry Eye Institute to promote education among eye care providers, and shares tips to help other ODs to get started or revitalize their d…

Do the status of the fovea and/or the timing of surgery affect visual outcomes following RRD repair? Join New Retina Radio Journal Club host Lediana Goduni, MD, as she and panelists Matt Starr, MD, and Joshua Uhr, MD, dissect the findings of a recent paper exploring this question. After the break, the trio discusses tactics for overcoming challenge…

Nathan M. Radcliffe, MD, joins Blake Williamson, MD, MPH, and Gary Wörtz, MD, to share his experiences managing complex patients with advanced-stage glaucoma. He shares a specific case of an 83-year-old man with a cataract and exfoliation glaucoma with an IOP of 56 mm Hg. Dr. Radcliffe walks through how he managed complications he encountered durin…